<it>MDM2 </it>SNP309 promoter polymorphism and <it>p53 </it>mutations in urinary bladder carcinoma stage T1
<p>Abstract</p> <p>Background</p> <p>Urinary bladder carcinoma stage T1 is an unpredictable disease that in some cases has a good prognosis with only local or no recurrence, but in others can appear as a more aggressive tumor with progression to more advanced stages. Th...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2013-01-01
|
| Series: | BMC Urology |
| Online Access: | http://www.biomedcentral.com/1471-2490/13/5 |